Catalent lands 2 new partnerships, including for glioblastoma drug; US drops $153M into pandemic preparedness
It’s been a quiet few weeks for one of the busiest CDMOs out there, but Catalent broke its lull with the announcement of two partnerships …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
